Skip to Content
Merck

GF31001960

Bismuth

foil, 25x25mm, thickness 2.0mm, 100%

Synonym(s):

Bismuth, BI000300

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
Bi
CAS Number:
Molecular Weight:
208.98
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141706
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


vapor pressure

<0.1 mmHg ( 20 °C)

assay

100%

form

foil

manufacturer/tradename

Goodfellow 310-019-60

resistivity

129 μΩ-cm, 20°C

size × thickness

25x25 mm × 2.0 mm

bp

1560 °C (lit.)

mp

271 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

SMILES string

[Bi]

InChI

1S/Bi

InChI key

JCXGWMGPZLAOME-UHFFFAOYSA-N

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow


Still not finding the right product?

Explore all of our products under Bismuth




Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials